Network opportunity!
3 year @cancerresearchuk.org funded Research Fellow post in the @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social alongside David Palmer in @bsmsmedschool.bsky.social working on RUNX1 mutations in CML.
Deadline Mar 8th. Applyπfor mid-Mar interviews and May start date
17.02.2026 10:04
π 2
π 0
π¬ 0
π 0
Research Fellow in Biochemistry & Biomedicine Ref: 43149 (Fixed Term) - Job page - University of Sussex Job Search
We're hiring a new 3 yr postdoc!
Join us for an exciting new CRUK funded project targeting RUNX1 mutations in CML in a highly supportive environment within @sussexbcr.bsky.social @biochembiomeduos.bsky.social @sussexcancer.org
Applyπ, advert closes 8th March.
jobs.sussex.ac.uk/job/4fee4e78...
09.02.2026 14:04
π 7
π 3
π¬ 0
π 2
Good news Friday!
Congratulations to @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social @sussex.ac.uk who have received their first funding from @cancerresearchuk.org with @uhsussex.bsky.social Clinical Fellow Dr David Palmer to progress their studies targeting RUNX1 mutations in CML. π
06.02.2026 14:54
π 5
π 0
π¬ 0
π 0
Beyond pleased to announce our lab has secured its first @cancerresearchuk.org funding with an Early Detection & Diagnosis Project Award titled:
'Detecting and targeting translation inhibitor sensitive RUNX1 mutations in Chronic Myeloid Leukaemia'
1/5
www.cancerresearchuk.org/for-research...
02.02.2026 08:01
π 10
π 2
π¬ 2
π 1
ποΈ New pre-print postedποΈ
Dr Okan Sevim from @rhysmorganlab.bsky.social @biochembiomeduos.bsky.social @sussex.ac.uk begins the publication of his doctoral work examining Wnt/B-catenin crosstalk with the RNA Binding Protein LIN28B and its potential for dual drug targeting in acute myeloid leukaemia. π
30.01.2026 16:46
π 2
π 1
π¬ 0
π 0
Dual targeting a LIN28B:Ξ²-catenin axis in acute myeloid leukaemia
Wnt/Ξ²-catenin signalling is dysregulated across several haematological malignancies, including acute myeloid leukaemia (AML), where is lacks effective targeting strategies. Previously, we discovered that Ξ²-catenin interacts with several RNA-binding proteins (RBP), and binds mRNA indirectly, indicating contributions to the post-transcriptional landscape of leukaemia cells. Here, we found the most frequent RBP-binding motif amongst Ξ²-catenin-bound mRNAs was the GGAG motif targeted by the oncofoetal expressed miRNA-regulating RBP LIN28B. We detected the Ξ²-catenin:LIN28B interaction in lymphoid and myeloid cell lines, and primary human CD34βΊ fetal liver-derived haematopoietic stem cells. LIN28B positively regulated Wnt signalling capacity by regulating LEF1 expression through a post-transcriptional mechanism requiring the let7 miRNA axis. Further miRNA sequencing of Ξ²-catenin- and LIN28B-depleted myeloid cells revealed both potential cooperative and antagonistic function in miRNA regulation. Finally, dual-targeting both Ξ²-catenin and LIN28B through either genetic or pharmacological means preferentially killed AML cells. These data reveal a potential novel synthetically lethal relationship in AML which could be exploited in the rare AML subsets where LIN28B expression becomes reactivated ### Competing Interest Statement The authors have declared no competing interest. Kay Kendall Leukaemia Fund, https://ror.org/03j2wfg84, KKL1051, KKL1446 Leukaemia & Myeloma Research UK, 4-5/06.21R ChildrenΒs Cancer & Leukaemia Group, CCLGA 2023 16 Morgan Republic of TΓΌrkiye Ministry of National Education
Very pleased to share our latest pre-print which showcases the incredible hard work and skill of Dr Okan Sevim.
Our continued exploration of Ξ²-catenin's contribution to the post transcriptional landscape of blood cells led us to a LIN28B interaction.
1/7
www.biorxiv.org/content/10.6...
28.01.2026 08:52
π 10
π 3
π¬ 2
π 2
πNew network opportunity!π
Prof @mitchell.science at @bsmsmedschool.bsky.social is advertising a new 3yr @leukaemiauk.bsky.social funded PDRA using mechanistic models to identify B-cell lymphoma therapeutic vulnerabilities.
Expected start date: Aprilβ26
Applyπby 01/03/2026 and join Sussex BCR!
30.01.2026 16:33
π 3
π 2
π¬ 0
π 0
We are recruiting a postdoctoral research fellow. | Mitchell Lab
We're excited to announce that we're looking for a postdoctoral research to join our team!
Weβre excited to announce that weβre looking for a postdoctoral research to join our team!
This is an opportunity to lead an exciting project aiming to push the boundaries of personalised medicine through integrating data, simulation and lab experiments.
Plz share
mitchell.science/talk/we-are-...
28.01.2026 10:58
π 5
π 5
π¬ 0
π 1
Many thanks to all the co-authors at @sussexbcr.bsky.social @bsmsmedschool.bsky.social
@sussex.ac.uk @sussexcancer.org @biochembiomeduos.bsky.social @ox.ac.uk who contributed to the study, funders for kindly supporting our work, and all our patients who selflessly donate samples for research.
7/7
28.01.2026 08:52
π 2
π 2
π¬ 0
π 0
We now have a LinkedIn page!
Please follow for the latest updates on research funding, publications, events, scientific/clinical discoveries and job vacancies!
www.linkedin.com/in/sussex-bl...
09.01.2026 15:22
π 0
π 0
π¬ 0
π 0
Happy new year from Sussex Blood Cancer Research!
If youβre an ambitious haematology scientist/clinician seeking Fellowships in 2026 to establish your own research lab why not consider @sussex.ac.uk Life Sciences as your host.
Information, support and policy ππ
www.sussex.ac.uk/webteam/gate...
02.01.2026 15:09
π 2
π 2
π¬ 0
π 0
Many thanks to all co-authors at @sussexbcr.bsky.social @bsmsmedschool.bsky.social @sussex.ac.uk @sussexcancer.org @biochembiomeduos.bsky.social and beyond who contributed to the study, funders for kindly supporting our work, and all our patients who selflessly donate samples for research.
19.12.2025 14:22
π 1
π 1
π¬ 0
π 0
π Network pre-print notification!π
New pre-print posted from @rhysmorganlab.bsky.social in @sussex.ac.uk led by Drs Hyun Park from @bsmsmedschool.bsky.social and Okan Sevim from @biochembiomeduos.bsky.social revealing a new regulator of leukaemia and stem cell growth; a deadenylase known as TOE1.
19.12.2025 14:30
π 3
π 2
π¬ 0
π 0
Fresh from presentation at @ash.hematology.org #ASH2025, pleased to present our latest pre-print showcasing the hard work of Drs Hyun Park & Okan Sevim. Exploration of b-cateninβs post-transcriptional role has revealed a novel AML cell and stem cell regulator; TOE1.
www.biorxiv.org/content/10.6...
19.12.2025 14:22
π 2
π 1
π¬ 1
π 1
Well done to Drs Hyun Park and Aaron Goff from @biochembiomeduos.bsky.social @bsmsmedschool.bsky.social @sussexbcr.bsky.social whoβve both had abstracts accepted for presentation at the @ash.hematology.org 2025 meeting in December, and been awarded ASH achievement awards!
See you in Orlando! πΊπΈ
07.11.2025 16:29
π 3
π 2
π¬ 0
π 0
Tonight was the U.K. premier of βGoodbye Breastsβ written, directed and produced by Joanne Callaghan, documenting her remarkable breast cancer story. A must see!
@gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk
11.11.2025 22:33
π 2
π 2
π¬ 0
π 0
Looking for a PhD on stem cells, microenvironment and gene regulation/alternative splicing. Join us for this great project with @whatchamacaulay.bsky.social
21.10.2025 15:29
π 7
π 5
π¬ 0
π 0
Prof. Tim Humphrey and Dr. Rhys Morgan both gave talks at the recent "Science CafΓ©" hosted by the Sussex Cancer Fund in partnership with the Macmillan Horizon Centre. A fabulous series of short talks for anyone interested in hearing a little more about the latest developments in cancer research.
30.09.2025 14:41
π 2
π 2
π¬ 0
π 0
πΎNew promotion in the network! π
A massive congratulations to Simon Mitchell @mitchell.science from @bsmsmedschool.bsky.social recently promoted to Professor!
Simon has transformed the Cancer Research portfolio at Sussex with his work at the Sussex BCR and the creation of @sussexcancer.org
πππ
11.10.2025 15:47
π 2
π 1
π¬ 0
π 0
Excited to have been promoted to Professor in Cancer Systems Biology at @bsmsmedschool.bsky.social, University of Sussex, @uniofbrighton.bsky.social
09.10.2025 20:20
π 11
π 3
π¬ 2
π 1
π°New funding updateπ°
Congratulations @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social for obtaining funding from @bloodcanceruk.bsky.social to target abnormal cell signalling mechanisms in AML.
This is now 1 of 6 active Blood Cancer UK grants in our growing network at Sussex. π π¬π§¬π₯Όπ©Έ
07.10.2025 06:53
π 4
π 2
π¬ 0
π 0
Very grateful to have been awarded our first @bloodcanceruk.bsky.social research grant over the summer for our work targeting aberrant Wnt/Ξ²-catenin signalling in acute myeloid leukaemia (AML).
Our new project headed by Dr Wagstaff begins Oct 1st developing new ways to target oncogenic Ξ²-catenin π
30.09.2025 15:06
π 11
π 2
π¬ 2
π 1
Delighted to wave the flag for @gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk together with Rhys Morgan at the Science Cafe, MacMillan Horizon centre today. Thanks to Rebecca Herbertson and Stephen Robinson for organizing.
@rhysmorganlab.bsky.social
29.09.2025 20:26
π 6
π 1
π¬ 0
π 1
Our Co-Directors Prof @chrispepper68.bsky.social and Dr @rhysmorganlab.bsky.social explain the mission and vision for the Sussex Blood Cancer Research network.
@sussexcancer.org @bsmsmedschool.bsky.social @biochembiomeduos.bsky.social
23.09.2025 16:17
π 5
π 5
π¬ 0
π 0
Prof Chris Pepper and Dr Rhys Morgan - Sussex Blood Cancer Research
YouTube video by Brighton and Sussex Medical School
π‘ How are #BSMS researchers working to change the future of blood cancer?
Prof Chris Pepper and Dr Rhys Morgan share their journey, their goals and why this research matters.
βΆWatch here: www.youtube.com/watch?v=0EwD...
@sussexbcr.bsky.social #MedicalResearch
23.09.2025 07:33
π 5
π 2
π¬ 0
π 1